Johnson & Johnson completes Abiomed acquisition
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
Morgan Stanley gives J&J overweight rating, says stock looks cheap
Johnson & Johnson to split into 2 public companies : NPR
Johnson & Johnson | LinkedIn
Johnson & Johnson – Products, Recalls, Lawsuits & Scandals
J&J plans to split into two companies, separating consumer products and pharmaceutical businesses
Questions about Johnson & Johnson vaccine - Mayo Clinic Health System
Johnson & Johnson CEO Alex Gorsky's Message Regarding Recent US Events
Johnson & Johnson, Under Fire, Has Track Record Of Weathering Trouble : NPR
4 Ways Johnson & Johnson Is Cultivating Outside-the-Box Innovations for COVID-19
Amazon.com: Johnson & Johnson First Aid To Go Kit (Pack of 12 Items) : Health & Household
JOHNSON'S® | Johnson & Johnson Pediatrics
J&J split could give consumer marketers badly needed freedom | Ad Age
Johnson & Johnson to end global sales of talc-based baby powder | The Japan Times
J&J announces IPO prices for consumer spinoff Kenvue
Johnson & Johnson to spin off consumer arm to focus on medical division | Healthcare industry | The Guardian
CDC: J&J COVID-19 vaccine no longer available in U.S.
Johnson's® New 100% Ingredient Transparency Disclosure for Its Baby Products | Johnson & Johnson
What You Should Know About Johnson & Johnson's COVID-19 Vaccine
A Second Chance for Johnson & Johnson in Court - WSJ
Johnson & Johnson to pay $8.9 billion to settle claims baby powder, other talc products caused cancer - ABC News
JNJ Stock Price and Chart — NYSE:JNJ — TradingView
Johnson & Johnson COVID-19 Vaccine: 6 Facts You Should Know | Cone Health
Vietnam approves Johnson & Johnson's COVID-19 vaccine as daily cases hit record | Reuters
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results | Business Wire
